Lately, the most promising remedy, human keratinocyte growth factor (KGF-1), has been shown to reduce the duration and severity of OM; however, according to Schubert et al., 63% of patients still develop mucositis, and the treatment is not devoid of side effects [22]. The gene discussed is FGF7; the disease is ocular melanoma.